CA
NZ
UK
AU
IND
US
Ruth Ann Marshall, a director of Conagra Brands Inc. (NYSE:CAG), filed a Form 4 on September 3, 2026, reporting the acquisition of 1,629.42 shares of common stock on September 1, 2026, in connection with deferred director's fees under the company's Directors' Deferred Compensation Plan.
Paul W. Breaux, Vice President, General Counsel, Secretary, and Chief Compliance Officer of Carvana Co., filed a Form 4 on September 3, 2026, disclosing the withholding of shares to cover taxes upon the vesting of restricted stock units.
Christopher R. Cline, Chief Financial Officer of Travere Therapeutics, Inc., filed a statement of changes in beneficial ownership on September 3, 2026, reporting a sale of 642 shares of common stock on September 2, 2026, to cover tax withholding obligations tied to vested restricted …
Stephen R. Palmer, Vice President of Accounting at Carvana Co. (NYSE:CVNA), filed a Form 4 on September 3, 2026, disclosing three transactions in Class A Common Stock on September 1, 2026, including shares withheld for taxes and open-market sales executed under a Rule 10b5-1 …
Benjamin E. Huston, Chief Operating Officer of Carvana Co. (NYSE:CVNA), filed a Form 4 on September 3, 2026, reporting transactions in Class A Common Stock dated September 1, 2026, including a tax withholding on restricted stock unit vesting and two open-market sales executed under …
Michael Parini, Chief Legal Officer of Biogen Inc., filed a Form 4 on September 3, 2026, disclosing the acquisition of 7,405 restricted stock units on September 1, 2026.
A Form 4 filed with the SEC on September 3, 2026 discloses that Craig Arnold, a director of Honeywell Aerospace Inc. (NASDAQ:HONA), purchased 6,400 shares of common stock on September 1, 2026.
Daniel G. Wilson, Chief Financial Officer of iRhythm Holdings, Inc., filed a Form 4 on September 3, 2026, disclosing the sale of 773 shares of common stock on September 2, 2026, to cover tax withholding obligations tied to the vesting of Restricted Stock Units.
Edward T. Archer, Executive Vice President of Sales and Marketing at Fabrinet, filed a Form 4 on September 3, 2026, disclosing the sale of 2,500 ordinary shares of Fabrinet (NYSE:FN) across two transactions on the same date.
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (NYSE:HIMS), filed a Form 4 on September 3, 2026, disclosing the sale of 3,458 shares of Class A Common Stock on September 2, 2026.
Please wait processing your request...